PUMA BIOTECHNOLOGY, INC. (PBYI) Total liabilities 2017–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) total liabilities at each fiscal year-end, per SEC filings.
$86.0MFY2025 · since FY2017: $112.2M → $86.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $86.0M | -29.1% |
| FY2024 | $121.2M | -31.6% |
| FY2023 | $177.1M | -11.7% |
| FY2022 | $200.5M | -12.5% |
| FY2021 | $229.0M | -8.5% |
| FY2020 | $250.2M | +15.1% |
| FY2019 | $217.4M | -3.3% |
| FY2018 | $224.8M | +100.3% |
| FY2017 | $112.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice